📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant (2021)

First Author: Heath P

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.05.13.21256639

Publication URI: http://dx.doi.org/10.1101/2021.05.13.21256639

Type: Preprint